July 21, 2025

Akero Therapeutics (AKRO) Stock Analysis: A 46.51% Upside Potential in the Biotechnology Space

For investors with an eye on the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) presents a compelling opportunity, boasting a potential upside of 46.51% according to analyst targets. As a..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Potential 26.64% Upside in Biotech Innovation

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is gaining the attention of investors with its promising pipeline in the biotechnology sector, particularly focusing on metabolic dysfunction-associated steatohepatitis (MASH). This Pennsylvania-based company, with..

Legend Biotech Corporation (LEGN): Explosive Growth Potential with 83.74% Upside

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of the biotechnology sector with its innovative approach to cancer treatment and a robust pipeline of novel cell therapies. This U.S.-based..

Corcept Therapeutics (CORT): Investor Outlook with Nearly 95% Upside Potential

For investors with a keen eye on the biotechnology sector, Corcept Therapeutics Incorporated (NASDAQ: CORT) presents an intriguing opportunity. With a robust market capitalization of $7.51 billion and a focus..

Charles River Laboratories (CRL) Investor Outlook: Navigating Challenges with Strategic Opportunities

Charles River Laboratories International, Inc. (NYSE: CRL) is a significant player in the healthcare sector, primarily focused on diagnostics and research. With a market capitalization of $7.59 billion, this Massachusetts-based..

Telix Pharmaceuticals Limited (TLX): Analyst Ratings Signal 40% Potential Upside in Biotech Innovator

Telix Pharmaceuticals Limited (TLX), a burgeoning player in the healthcare sector, specifically within the biotechnology industry, is capturing investor attention with its promising growth potential and innovative approach to cancer..

ICON plc (ICLR) Stock Analysis: Exploring the 22% Potential Upside for Investors

ICON plc (NASDAQ: ICLR), a pivotal player in the healthcare sector, has carved out a niche within the diagnostics and research industry. Headquartered in Dublin, Ireland, this clinical research organization..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Navigating Volatility with Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is drawing significant interest from investors as it carves a niche in the biotechnology sector, focusing on rare neuroendocrine diseases. With a market capitalization of..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Assessing Growth Potential Amidst Challenging Metrics

Bausch + Lomb Corporation (NYSE: BLCO), a prominent name in the healthcare sector, stands out in the medical instruments and supplies industry with its broad international presence. Headquartered in Vaughan,..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unveiling a 58.51% Potential Upside with Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has been making waves in the biotechnology sector, primarily focusing on central nervous system (CNS) disorders. With a market capitalization of $5.5 billion, this New..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Potential Upside Amid Industry Challenges

Illumina, Inc. (NASDAQ: ILMN) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. Based in the United States, this genomic powerhouse is renowned..

RadNet, Inc. (RDNT) Stock Analysis: Why Analysts Predict a 24% Upside

RadNet, Inc. (NASDAQ: RDNT), a significant player in the healthcare sector, specifically in diagnostics and research, has captured the attention of individual investors and analysts alike. With a current market..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 96% Upside Potential in the Healthcare Sector

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare plans industry, presents an intriguing opportunity for investors, particularly those navigating the evolving dynamics of managed healthcare services in..

ADMA Biologics Inc (ADMA) Stock Analysis: A Promising 76% Potential Upside for Investors

ADMA Biologics Inc (NASDAQ: ADMA) is capturing the attention of investors with a robust potential upside of 76.27%, according to analyst ratings. Operating in the healthcare sector, specifically within the..

Soleno Therapeutics, Inc. (SLNO) Investor Outlook: Biotech Stock with a 27% Upside Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is making headlines in the healthcare sector, specifically within the biotechnology industry, as it charts a promising path with its clinical-stage biopharmaceutical pursuits. Headquartered in..

Bio-Techne Corp (TECH) Investor Outlook: Analyzing the 29.33% Potential Upside

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology industry, is drawing attention from investors with its promising 29.33% potential upside. With a market capitalization of $8.16 billion, this..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a Potential 247% Upside with Groundbreaking Vaccine Innovations

Vaxcyte, Inc. (NASDAQ: PCVX) is navigating the biotechnology landscape with a promising portfolio of vaccines designed to combat bacterial infectious diseases. With a market capitalization of $4.67 billion, this clinical-stage..

Verona Pharma (VRNA) Stock Analysis: Strong Buy Ratings and 13.53% Potential Upside

Verona Pharma plc (NASDAQ: VRNA) is making waves in the biotechnology sector, capturing investor attention with its robust portfolio and promising market performance. Headquartered in London and operating in the..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Innovator with 7.32% Potential Upside

Insmed Incorporated (NASDAQ: INSM) stands out in the biotechnology sector with its focus on developing and commercializing therapies for serious and rare diseases. With a market capitalization of $19.48 billion,..

Inspire Medical Systems, Inc. (INSP): Growth Potential and Analyst Ratings Signal a Bright Future

Inspire Medical Systems, Inc. (NASDAQ: INSP) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.74 billion, Inspire Medical is at..

Search

Funds

July 21, 2025

Search

Funds

July 21, 2025

FTSE 100

Funds